List of Biotech, Pharmaceutical & Life Sciences companies in Utah - 59

Altitude Lab is a biotech and health care incubator offering lab and office space, funding, mentoring, and entrepreneurial education.

We are the curious. Ancestry®, the global leader in family history and consumer genomics, empowers journeys of personal discovery to enrich lives. With our unparalleled collection of more than 60 billion records from 88 countries, over 3 million subscribers and over 25 million people in our growing DNA network, customers can discover their family story and gain a new level of understanding about their lives. Over the past 40 years, we've built trusted relationships with millions of people who have chosen us as the platform for discovering, preserving and sharing the most important information about themselves and their families. Ancestry has over 1,300 employees in locations across the globe. Our headquarters is in Lehi, Utah and our offices are located in San Francisco, California; Lehi, Utah; Dublin, Ireland; Paris, France; London, England; Sydney, Australia; and Grafing, Germany. We are committed to our location flexible work approach, allowing you to work from where you want — in an office or from home or a hybrid of both (subject to location restrictions and roles that are required to be in the office). We will continue to hire and promote beyond the boundaries of our office locations, to enable broadened possibilities for employee diversity. We're passionate about using technology to create simple, useful, and delightful experiences that enrich lives and connect families and have accelerated product innovation to enable everyone to discover, craft and connect around their family story. Ancestry is continually looking for talented, hard-working and curious individuals who are passionate about bringing this mission to life. Sound like you? Join the curious. Visit https://careers.ancestry.com

Applied Biosensors was established in 2013 to transform the production of life-saving medicines. The company has developed a biosensors and analytics platform for continuous monitoring of critical process parameters designed specifically for the biomanufacturing industry. The platform generates 1000X more process data in real-time compared to current off-line manual systems, and enables predictive analytics and models based on artificial intelligence and machine learning. Importantly, it is adaptable and scalable for any bioreactor: single use, glass or stainless steel, and it can be used in R&D and can scale up for GMP. Applied Biosensors mission is to provide its customers with comprehensive, high-quality solutions that improve productivity and process reliability thus resulting in superior biomanufacturing and life science products. For more information, visit www.appliedbiosensors.com

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests. With more than 3,000 employees, ARUP offers in excess of 3,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays. ARUP is an Equal Opportunity Employer M/F/D/V and supports a drug-free environment. Scammers have been posing as ARUP recruiters to target jobseekers using fraudulent email addresses and social media accounts. ARUP recruiters will only contact you with legitimate offers by calling from 800-522-2787 or 801-583-2787 or emailing from an address ending in @aruplab.com. Read our full fraud statement on aruplab.com/careers

Bioassay Sciences is an internationally recognized scientific and engineering consulting firm dedicated to the design, support and validation of bioassays. We use a platform approach to rapid bioassay development, systems suitability, parallelism and control. Bioassay Sciences has years of experience in the bioassay space and has worked with clients and regulatory agencies to achieve results in bioassay design and validation.

With more than 25 years of molecular experience, BioFire Diagnostics, LLC (now bioMérieux) sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BioFire® FilmArray® System. The FDA-cleared BioFire System panels test for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes. Whether you’re trying to determine optimal therapy for a septic patient or pinpoint which respiratory pathogen is making a young child sick, the BioFire System can provide definitive answers—fast.

We believe a world yearning for hope and joy needs the graduates of Brigham Young University—disciples of Jesus Christ who are driven by love for God and His children and who are prepared to serve and lead. This preparation demands a unique university model: at BYU, belief enhances inquiry, study amplifies faith, and revelation leads to rich understanding; at BYU, helping students develop their full divine potential is central to both our teaching and our scholarship. As the flagship higher education institution of The Church of Jesus Christ of Latter-day Saints, BYU strives to be among the exceptional universities in the world and an essential university for the world.

Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra's high throughput LSA, LSA-XT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented microfluidics technology with real-time High-Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading analysis and visualization software. These systems deliver up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing label-free platforms. The LSA-XT and Ultra instruments introduce enhancements to Carterra’s flagship product, the LSA, increasing sensitivity and enabling new applications in biotherapeutic discovery and small molecule analysis. Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity. For additional information, please visit www.carterra-bio.com.

Chapul is the true pioneer behind the consumption of insects as a nutritious and sustainable alternative protein source. Chapul launched in 2012 with a successful Kickstarter campaign, and followed that up with an appearance on NBC's Shark Tank, where it secured an investment from Mark Cuban. Since then, Chapul has continued its mission of introducing insects into Western cuisine as a healthy and sustainable food, and is available at retail stores across the the U.S. and Canada in addition to online at www.chapul.com.

Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q2 2024, we have provided over 180 million units of essential medicines to hospitals, enough to help treat over 80 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more than $30 a vial and no more than $55 for a pack of five pre-filled pens, regardless of insurance status. WHY CIVICA? Because patients should have the essential medicines they need when they need them. As a rapidly growing, entrepreneurial, nonprofit generic drug company our mission is to ensure quality generic medicines are accessible and affordable to everyone.

Clene Inc., a clinical-stage biopharmaceutical company, focuses on the development of various therapeutics for neurodegenerative diseases. The company has a nanotechnology drug platform for the development of orally administered neurotherapeutic drugs. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson’s; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company’s products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; and NM-PtAu7, a gold-platinum CSN therapeutic. Clene Inc. is based in Salt Lake City, Utah.

CoNextions Medical is focused on developing novel solutions for tendon repair. For almost 2,000 years, suture has been the standard of care for the repair of injured tendons. We believe it is time for something new.

Culmination is changing the world by discovering better health. We provide unparalleled value to health care organizations by unlocking biological data and enriching it with clinical, claims, and genomic data. We are on a journey to radically improve everyone's future health care experience. Culmination Bio will become the trusted source for health care insights and for generating discoveries that improve people’s lives.

Curza is a small molecule therapeutics development company. Curza has developed a new class of antibiotics that are active and selective against Gram-negative pathogens.

Our research focuses on the activation of a plant’s metabolic pathways, crop responses to stress, control of reactive oxygen species, gene upregulation, and enhancement of nutrient uptake. Through this core research, we develop novel crop solutions to support healthy and abundant food production worldwide.

DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we hope will be a profound therapeutic option for millions of patients suffering from the debilitating effects of back pain. DiscGenics’ first product candidate, IDCT, is a homologous, allogeneic, injectable cell therapy for the treatment of patients with mild to moderate degenerative disc disease.

Dyad Labs (A Mérieux NutriSciences Company) is an ISO/IEC 17025:2017 accredited contract laboratory providing specialized chemistry and microbiology testing services to the Nutraceutical and Food & Beverage industries since 2008. Dyad Labs’ mission is to professionally, effectively, and ethically perform testing for our customers to produce accurate and precise results while offering exceptional customer service and support by meeting and exceeding customer expectations. Led by a management team of experts that have diverse backgrounds in pharmaceutical, nutraceutical, and bioanalytical research fields, Dyad Labs is constantly working on new technologies that offer cutting edge solutions to increasing regulatory requirements and calls for full transparency of the supply chain.

We are a global leader in biochemical reagents, assays, and peptides for academic research and pharmaceutical development. Echelon values integrity in business and providing superior service. We serve all our stakeholders with focus on our customers so together we can continue Elevating Science!

ELITechGroup MDx, part of Bruker Corporation, is a leading provider of molecular diagnostics solutions, designed to meet the diverse and growing needs of laboratories worldwide. Headquartered in Turin, Italy, at ELITechGroup SpA, it serves as a key center for manufacturing, logistics, and business operations, making it one of the most prominent molecular biology hubs in Europe. Over the years, ELITechGroup MDx has developed a comprehensive suite of PCR technologies, including the revolutionary Minor Groove Binder (MGB). In 2016, ELITechGroup revolutionized molecular diagnostics with the introduction of ELITe InGenius, its first fully automated sample-to-result (S2R) system. Since then, the company has continued to expand the platform's capabilities, offering nearly 60 CE-IVD parameters and validating over 20 different sample matrices. Building on this success, ELITechGroup launched ELITe BeGenius in 2021, its second S2R platform, further solidifying its commitment to delivering superior workflow efficiency and guaranteed performance. With a robust pipeline of assays, instruments, and software, the company ensures that laboratories remain at the cutting edge of molecular diagnostics. All its products meet the highest global quality and regulatory standards and are fully compliant with the latest IVD regulations. ELITechGroup MDx is certified by DEKRA Certification BV and operates under a stringent quality management system in compliance with ISO 9001:2015 and EN ISO 13485:2016 standards according to the Medical Device Single Audit Program (MDSAP). In addition to its extensive product portfolio, ELITechGroup MDx provides expert technical support, including training, on-site assistance, and customized solutions from sample to result, ensuring that laboratories receive the highest level of service and performance.

Epitel is a digital health company modernizing brain health solutions to improve seizure monitoring and detection.

Eris Biotech is a biotech company that develops drugs that only activate under low oxygen (hypoxic) environments. These drugs are referred to as hypoxia-activated prodrugs or HAPs. Their innovative treatments specifically target the tumor microenvironment, ensuring maximum effectiveness.

Our Vision: To revolutionize the structural heart market with new material, design and manufacturing technology expanding patient access, improving product performance and significantly reducing costs.

Halia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.

iVeena Delivery Systems, Inc. is a privately held, clinical stage ophthalmology company developing non-surgical, non-invasive, pharmacologic innovations.

JSK’s Therapeutics’ mission is to aggressively develop JSK to treat multiple types of cancer. We seek to position JSK as a leader in the evolving field of NO therapeutics for cancer treatment and co-therapeutic use as appropriate.

Leash Bio is a biotechnology company that is transforming drug design with a rich dataset built by screening millions of compounds against thousands of proteins to generate billions of data. They are pioneering AI-driven medicinal chemistry and unleashing machine learning to solve medicinal chemistry.

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company’s pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase II Clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH); TLANDO XR, an oral prodrug of testosterone for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, an oral prodrug of bioidentical testosterone that has completed phase I clinical trial for the treatment of NASH cirrhosis; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.

We identify the risk of developing Maternal Autoantibody Related Autism (MARA), a subtype of autism that is estimated to represent approximately 20% of overall cases, through a new type of risk assessment test for prospective mothers prior to (but not during) pregnancy, and for mothers during the early postnatal period. Our goal is to provide families with options to materially reduce the occurrence or severity of MARA. Our precision technology uses a blood test in women to identify the presence of a distinct cluster of autoantibodies that lead to MARA, thereby enabling the earliest risk assessment for the development of autism in a child.

MasterControl is on a mission to bring life-changing products to more people sooner. Everything we do is designed to help you develop, manufacture, and commercialize products that help people live longer, healthier, and more enjoyable lives. We offer the world's leading solution for product quality, helping highly regulated companies ensure quality and compliance in their life sciences operations. Our quality management system is the most established and used QMS in the industry and is used by the FDA, CDC, and ORA. And our digital manufacturing solution offers errorless and frictionless production by taking you 100% paperless on your shop floor. The results speak for themselves. MasterControl customers enjoy 80% faster post-production review times, 21% fewer deviations, and 100% right-first-time. There's a reason more than 1,000 global customers have used MasterControl to bring more than 250,000 life-changing products to market. Learn more today at mastercontrol.com.

Over 100 million Americans have either a pre-chronic illness, or a disease and the majority don’t even know it. Early detection, intervention and timely personal monitoring matters; but, improving wellbeing requires consumer interactions to be easy, convenient and fit naturally into their daily “life flow.” Medic.Life is a unique biotech startup focused on blending miniaturized assay systems, medical IoT, AI and mobile into a waste analyzer platform – a smart toilet – resolving pain points for everyday users and providers. Within 2 years, our technology will be found in clinics, senior care, primary care, pharmacies, retail outlets, and homes, while generating mountains of personal health data. As such, Medic is really a data company with a sophisticated user interface that captures, analyzes and trends vital health indicators every time our toilets are used and notifies users when anomalies are detected. It’s like having a Medic at your disposal. Medic.Life has a strong IP position with 60 patents granted and more than 90 pending so far. We are working with over 20 partners for our onboard science center (microfluidics, lab on chip, proprietary sensors) and seek to double that number in the 2020-21 timeframe. If you have miniaturized technology to analyze urine, feces, vitals, body composition and circulation, then please contact us.

As a global healthcare company, we understand customer needs and innovate and deliver medical solutions that transform patient care. Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

MTI designs, manufactures, and sells surgery and exam chairs and tables, medical cabinetry, stools, and many related accessories for the Podiatry, Otolaryngology, Dermatology, Plastic Surgery, Oral Surgery, and Ophthalmology specialties. The continued challenge of combating rising healthcare costs and advances in ambulatory medical care has influenced MTI to develop an entire family of power chairs/tables, cabinetry, seating, and accessories to meet the needs of medical professionals and patients in order to help deliver and receive quality medical care at reasonable costs.

Nelson Labs is a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. Nelson Labs serves over 3,500 customers across 15 facilities in the United States, Mexico, Asia, and Europe. We have a comprehensive array of over 800 laboratory tests supporting our customers from initial product development and sterilization validation, through regulatory approval and ongoing product testing for sterility, safety and quality assurance. We are regarded as a best-in-class partner with a strong track record of collaborating with customers to solve complex issues. Learn more about Nelson Labs at www.nelsonlabs.com. Safeguarding Global Health® - with every test we complete.

Noorda-COM Pre-Accreditation Status Commission on Osteopathic College Accreditation (COCA) predoc@osteopathic.org Noorda-COM is a private institution situated at the edge of the East Bay Golf Course in Provo, Utah. Our mission at Noorda-COM is to empower our students with essential personal and professional skills needed to be competent, confident, and compassionate osteopathic physicians who are dedicated to meeting the healthcare challenges of the communities in which they serve. Our values align with instilling and fostering cultural awareness and ethical leadership, embracing diversity, and inspiring a servant's heart towards caring for the poor and needy. Noorda-COM offers osteopathic programs endorsed by local universities, Brigham Young and Utah Valley. Over the course of our program, students will expand on their medical experiences through simulation, clinical rotation, clerkship, and research projects. Our local healthcare providers are willingly partnered with us to complete this clinical portion of a medical education. Noorda-COM curriculum utilizes a blended classroom structure. No large classrooms, no regularly scheduled classes. Students will make their own schedule to meet in groups to complete modules and are assessed based on their progress. Module content is continuously being improved, since our staff is able monitor which lessons are effective with students and lessons that are not. Our campus is designed with the intention to create a stress-free environment. In addition to the incredible mountain-range view, our campus will have other attractive amenities including comfortable study areas for single person or group use, student and faculty lounges, fitness and recreation areas including access to the golf course and will be adjacent to campus housing.

NuView Life Sciences is a clinical stage precision oncology company. The Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-activating Peptide Receptor is over-expressed on the surface of a wide range of cancer types at the onset of oncogenesis. NuView's NV-VPAC1 small molecule binding agent designed to identify and bind to the VPAC receptors has been utilized in clinical trials for binary in vitro and in vivo of confirmation of cancer. The NV-VPAC1 agent can be utilized to deliver existing therapeutics and new alpha and beta emitters. NuView will pair existing imaging and therapeutic radionuclides with NuViews proprietary agent and provide a Theranostics solution for patients and clinicians.

nView medical, based in Salt Lake City, UT, is a startup whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging technology — bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Capital Consortium for Pediatric Device Innovation, MedTech Innovator, HealthTech Arkansas, Dr. Kevin Foley, M.D., and Fusion Fund (Palo Alto, CA). Its founder, Cristian Atria, has had a progressive career with GE Healthcare in positions that range from development engineer to general manager with P&L responsibility. He has successfully assisted start-up and public companies with technology transfers, licensing, product development, regulatory approvals, and commercialization.

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive. Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions. Did you know? *1 in 8 couples struggle with infertility. *50% of in vitro fertilization (IVF) procedures fail. *50% of infertility is linked to men. *Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then. With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide. We help make parenthood possible. Learn more at www.PaternaBio.com Contact us: info@paternabio.com A New Paradigm in Human Reproduction.

Over the course of millions of years, nature evolved to create the world’s most awe-inspiring, life-changing health outcomes. Peel Therapeutics translates these evolutionary outliers to develop medicines for patients with cancer and inflammatory diseases. Using scientific and medical expertise, state-of-the-art technology and drug development knowledge, we redesign what nature offers into medicines for patients by tackling solubility, scalability, and bioavailability. Our clinical stage therapeutic pipeline treats a spectrum of devastating conditions, with a near-term focus on cancer and inflammation. At Peel Therapeutics, we push the limits of biology to develop highly effective and safe medicines for patients that transcend the incremental.

Phoenix PharmaLabs, Inc. (PPL) is a privately held preclinical drug discovery company focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction. PPL was founded in 2002 with the mission of bringing its new class of opioid pain therapies and addiction treatment to market. PPL has designed a novel family of ligands with high binding affinity at all three opiate receptors: mu, kappa and delta. These unique ligands, derived from opioid backbones using proprietary technology, have more balanced receptor activity than morphine and other opioids, with partial agonist / antagonist activity at mu, relatively higher, but not full, kappa agonist activity, and moderate delta activity. This profile results in first-ever opiate analgesics that appear to be non-addicting and free of all significant dangerous side effects. Studies of the drugs have been conducted by prominent scientists at leading institutions including Virginia Commonwealth University (VCU), the University of Michigan, SRI International and Torrey Pines Institute for Molecular Studies. Study results in rodents and monkeys performed by the National Institutes of Health (NIH) and SRI International Laboratories demonstrated the following: • Robust analgesic potency (8x - 60x stronger than morphine) • No dangerous narcotic effects • No signs of respiratory depression - at over 150x dosage • No death from overdose - even at 350x dosage • No physical dependence in naive rodents • Little or no abuse potential in monkeys • No dysphoria in monkeys • No inhibition of GI transport in rodents - even at 350x dosage • No significant diuresis in rodents • Does not precipitate withdrawal in dependent monkeys Since the drugs do not precipitate withdrawal, they offer very promising use for addiction therapy as a preferred substitute for methadone and buprenorphine.

PolarityTE, Inc., headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. PolarityTE's first regenerative tissue product is SkinTE®. PolarityTE has an open investigational new drug application (IND) for SkinTE® with the U.S. Food and Drug Administration (FDA) and is now pursuing the first of two pivotal studies on SkinTE® needed to support a biologics license application (BLA) for a chronic cutaneous ulcer indication. SkinTE® is available for investigational use only. Learn more at www.PolarityTE.com.

Q Therapeutics is a biotechnology company based out of 417 S Wakara Way, Salt Lake City, UT, United States.

Rebel Medicine is developing the next generation of local anesthetics that control pain locally and mitigate the need for opioids after surgery. Opioids after surgery can lead to addiction, respiratory depression, nausea, constipation, and death. These opioid-related adverse events are associated with prolonged hospitalizations and increased cost of care. Rebel’s long-acting local anesthetics will provide significant value to the customer, patient, and society alike by preventing addiction and reducing the cost of care. Headquartered in Salt Lake City, our team draws on firsthand experiences with active lifestyles to understand the real-world need for effective, non-opioid pain management solutions. This perspective drives our commitment to creating innovative solutions that improve patient outcomes.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.

Respro is an experienced, trusted resource providing brand protection public health services to a wide range of industries. Protect your brand and control your future with Respro's health, safety, and crisis management solutions.

RxCell is a biotechnology company that specializes in the development of advanced cell-based therapies for the treatment of various diseases and medical conditions.

At Scientia Vascular, we believe that without access, therapy can not exist. Through cutting-edge innovation, we're answering our calling to radically disrupt the way diseases of the brain are treated. Our teams have been at the forefront of neurovascular systems, pushing beyond established boundaries to deliver the products physicians and patients need most.

Scintillant Bioscience provides in vitro biology services for therapeutics discovery and preclinical development for all therapeutic modalities. We help clients with all aspects of drug discovery projects, including screening, hit-to-lead, lead optimization, and preclinical development. We develop, validate and implement cell-based assays, typically for high content imaging (HCI)/high content screening (HCS)/high content analysis (HCA) and other forms of automated microscopy, including time-lapse imaging. Additionally we provide a variety of other services, such as plate-reader assays, proteomics, molecular biology services and more. We are happy to work with you on any of your needs for biochemical or cell-based assay development, validation or implementation. We have developed drug-discovery assays using primary cells, cell lines and iPSC-derived cell types. We will custom build stably overexpressing-, mutant- or reporter-gene cell lines as required for your drug-discovery programs. Let us help with your drug-discovery challenges.

ScyTek Laboratories, Inc. a Utah, USA corporation involved in the manufacture of diagnostic reagents Special Stains, Antibodies, Hematology, Microbiology, Hematoxlyn

Second Heart Assist Inc. is a medtech startup company that will revolutionize the treatment of chronic heart failure (HF). With its novel aortic stent pump technologies, Second Heart will enhance the lives of millions who suffer from chronic HF worldwide.

Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Our vision is to deliver pivotal information to physicians early in pregnancy to help them to improve the health of their patients and reduce costs of healthcare delivery. The PreTRM® Test reports to a physician the individualized risk of premature birth, enabling earlier proactive interventions in patients with higher risk. We're also developing a robust pipeline of innovative tests focused on other complications of pregnancy, including preeclampsia, gestational diabetes, growth restriction, and others. Learn more about our values, culture, and open positions on our website.

Sethera is redefining the field of peptide therapeutics with a unique platform that integrates AI, mRNA display, and phage display technologies. We create extensive libraries of constrained peptides, providing unparalleled screening capabilities for drug discovery. Our mission is to accelerate the development of innovative therapies, partnering with industry leaders to bring groundbreaking treatments to market.

SINTX Technologies is an OEM ceramics company that develops and commercializes advanced ceramics for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of advanced ceramics for external partners.

Sorenson Genomics specializes in DNA testing in forensic science, and research projects. Their expertise in human genomics includes DNA genotyping, DNA sequencing, and fragment analysis for use in population genetics and human genotyping.

Spriaso is a biopharmaceutical company dedicated to improving therapeutics through innovative patient friendly product options. Spriaso has several candidates in development with a focus on the central nervous system (CNS) and gastrointestinal (GI) disorders. Our portfolio of unique products have successfully completed proof of principle clinical studies. In addition, Spriaso develops ANDA products and has received an FDA approved NDA. These products are available for out-license to a marketing partner and are protected by multiple issued and pending patents.

SymbioCellTech (SCT) is an early stage, university spin out, that has developed stem cell-based technology that achieves euglycemia (glucose control) in Type-1 Diabetes, and will soon be adapted for Type-2 Diabetes. The SCT proprietary Neo-Iset therapy, comprising both pancreatic islet and mesenchymal stem cells, can be administered in a simple out-patient procedure resulting in glucose control identical to that of a normal healthy individual. Backed by rigorous NIH, VA and privately funded research and resultant data, SCT has completed pre-clinical trials and is preparing for FDA submission and approval to begin well-designed, controlled, clinical trials treating humans suffering from Type-1 Diabetes. FDA Investigational New Animal Drug (INAD) approval for diabetic companion animals has been approved and canine clinical trials are ongoing with outstanding results and outcomes.

Tekholding is a research and development company driving sustainable innovation across diverse sectors including, healthcare, sustainable energy, and materials. With a focus on innovation at every stage, we are committed to advancing solutions that drive positive change and long-term viability in these essential fields.

Thunder Biotech, Inc. is an immune-oncology company developing patented MOTO-CAR™ technology - genetically engineered CAR macrophages - that help cancer patients' immune cells recognize and attack solid tumors. Traditional cancer treatments— like surgery, radiation, and chemotherapy—are often ineffective, invasive, and difficult to tolerate. Thunder Biotech is designing MOTO-CAR™s to be a more effective and humane therapy. Thunder Biotech's MOTO-CAR™s re-educate Tumor Associated Macrophages and restore their M1 ability to recognize and eliminate tumor cells. In addition, MOTO-CAR™s are armed with tumor specific receptors that directly adhere to the tumor cell surface allowing them to initiate tumor cell destruction and recruit the natural T cell response engaging them to eliminate the tumor. This T cell response will then provide the body with a memory response preventing tumor recurrence.

TikkunLev Therapeutics is on a mission to revolutionize the treatment of heart failure by targeting the underlying biology of failing heart muscle. Founded on the pioneering research of Professor Robin Shaw M.D., Ph.D., our lead program, TLT-101, is a precision therapy that targets the underlying protein trafficking defects in heart failure. Extensive preclinical data demonstrate an unprecedented efficacy and safety profile with our therapeutic approach. TLT-101 is in IND-enabling development for non-ischemic dilated cardiomyopathy (DCM), a severe and progressive disease that is a leading cause of heart failure. With cardiovascular disease remaining the leading global cause of death and 1 in 4 people expected to develop heart failure, our innovative approach aims to repair the heart and transform lives.

Varex Imaging Corporation is the world’s largest independent supplier of medical X-ray tubes and image processing solutions. From medical imaging to cargo screening and border security, our components are used by X-ray imaging system manufacturers everywhere to detect, diagnose, and protect. Our products are designed to harness the power of X-ray energy to pioneer advances in any application. This requires us to maintain an extensive catalog, and we are a leading supplier of high-voltage connectors, X-ray collimators, ionization chambers, mammography paddles, solid state automatic exposure control systems and buckies for digital imaging. As a leader in imaging components, our goal is to help our customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster. Our rich history spans 65+ years of dedication to the imaging industry, but our everyday work is devoted to our partners’ success.